NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 248 filers reported holding NEKTAR THERAPEUTICS in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,752 | -18.2% | 10,000 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $7,029 | -68.9% | 10,000 | 0.0% | 0.00% | -66.7% |
| Q4 2022 | $22,600 | -29.4% | 10,000 | 0.0% | 0.01% | -35.7% |
| Q3 2022 | $32,000 | -15.8% | 10,000 | 0.0% | 0.01% | -6.7% |
| Q2 2022 | $38,000 | -29.6% | 10,000 | 0.0% | 0.02% | -16.7% |
| Q1 2022 | $54,000 | -60.0% | 10,000 | 0.0% | 0.02% | -56.1% |
| Q4 2021 | $135,000 | -25.0% | 10,000 | 0.0% | 0.04% | -30.5% |
| Q3 2021 | $180,000 | +4.7% | 10,000 | 0.0% | 0.06% | +5.4% |
| Q2 2021 | $172,000 | -14.0% | 10,000 | 0.0% | 0.06% | -18.8% |
| Q1 2021 | $200,000 | +17.6% | 10,000 | 0.0% | 0.07% | +9.5% |
| Q4 2020 | $170,000 | +2.4% | 10,000 | 0.0% | 0.06% | -10.0% |
| Q3 2020 | $166,000 | -28.4% | 10,000 | 0.0% | 0.07% | -34.0% |
| Q2 2020 | $232,000 | +8.4% | 10,000 | -16.7% | 0.11% | -10.9% |
| Q1 2020 | $214,000 | -17.4% | 12,000 | 0.0% | 0.12% | +11.2% |
| Q4 2019 | $259,000 | +18.3% | 12,000 | 0.0% | 0.11% | +7.0% |
| Q3 2019 | $219,000 | -48.7% | 12,000 | 0.0% | 0.10% | -46.8% |
| Q2 2019 | $427,000 | +6.0% | 12,000 | 0.0% | 0.19% | +5.0% |
| Q1 2019 | $403,000 | +2.3% | 12,000 | 0.0% | 0.18% | -11.4% |
| Q4 2018 | $394,000 | – | 12,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |